MISSISSAUGA, Ontario / Dec 04, 2025 / Business Wire / Covalon Technologies Ltd . (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2025 financial results on Thursday, December 11, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Thursday, December 11, 2025, at 8:30am ET. To view,... Read More

MISSISSAUGA, Ontario / Nov 19, 2025 / Business Wire / Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the payment on November 18, 2025 of its first ever dividend – a special cash dividend of C$0.15 per common share – reflecting the Company’s strong financial performance and continued success in accelerating the adoption of its unique,... Read More

MISSISSAUGA, Ontario / Oct 21, 2025 / Business Wire / Covalon Technologies Ltd. (the “ Company” or “ Covalon” ) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Directors has declared a special cash dividend (the “ Special Dividend ”) in the aggregate amount of $4,112,711.55 CAD, being $0.15 CAD per common share of the Company to be paid on November 18, 2025 to... Read More

MISSISSAUGA, Ontario / Oct 20, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company improving lives through innovative wound care, vascular access, and surgical solutions, is pleased to announce its participation at the Planet MicroCap Showcase: TORONTO 2025, in partnership with MicroCapClub. Brent Ashton, Covalon’s Chief Executive... Read More

MISSISSAUGA, Ontario / Oct 07, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety and clinical outcomes, today announced its upcoming participation in the 2025 American Nurses Credentialing Center (ANCC) National Magnet ® & Pathway to Excellence Conference™ , taking place October 8–10, 2025 in... Read More

MISSISSAUGA, Ontario / Sep 25, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation in the Association of Pediatric Hematology/Oncology Nurses (APHON) 49th Annual Conference, September 25–27, 2025 in Providence, Rhode Island. The annual conference, attended by more than 800 nurse leaders from across the... Read More

MISSISSAUGA, Ontario / Sep 23, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. Abe Schwartz has been elected Chair of the Board of the Company. Mr. Schwartz succeeds Mr. Amir Boloor, who has decided to step down as a director and Executive Chair of Covalon with effect today. Mr. Schwartz, a member of... Read More

MISSISSAUGA, Ontario / Sep 18, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation at the Association for Vascular Access (AVA) Annual Scientific Meeting in Orlando, Florida, from September 18–21, 2025. Attendees will have the opportunity to explore Covalon’s innovative vascular access and infection... Read More

Peer-reviewed study reports a 78% reduction in hospital-wide CLABSI rates from 2023 to 2024 MISSISSAUGA, Ontario / Sep 16, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of results from a peer-reviewed clinical study investigating the use of Covalon’s VALGuard® Vascular Access Line Guard in the... Read More

Sequential QoQ Revenue Growth of 10.4%, Adjusted EBITDA Growth of 52% Trailing Twelve Months Revenue Growth of 13%, Adjusted EBITDA Growth of 116% MISSISSAUGA, Ontario / Aug 21, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 third quarter results for the period ended June 30, 2025, along with a... Read More

Improving Access for U.S. Investors and Supporting Share Price Appreciation for Canadian MedTech Innovator MISSISSAUGA, Ontario / Aug 20, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that its common shares are now eligible for electronic clearing and settlement in the United States through The... Read More

MISSISSAUGA, Ontario / Aug 14, 2025 / Business Wire / The date in the first paragraph should read: Thursday, August 21, 2025 (instead of Wednesday, August 21, 2025). The updated release reads: COVALON ANNOUNCES CONFERENCE CALL TO DISCUSS THIRD QUARTER FISCAL 2025 FINANCIAL RESULTS Covalon Technologies Ltd . (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3... Read More

MISSISSAUGA, Ontario / Aug 14, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2025 financial results on Wednesday, August 21, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, August 21, 2025, at 8:30am ET. To view, listen to, and... Read More

Year-To-Date Revenue Grew 21% and Year-To-Date Adjusted EBITDA Increased by 57% MISSISSAUGA, Ontario / May 28, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 second quarter results for the period ended March 31, 2025, along with a number of important recent achievements and highlights. Brent... Read More

Study results have been selected for presentation at two prestigious scientific meetings and are advancing to publication MISSISSAUGA, Ontario / May 27, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that exciting results from a clinical study evaluating the use of its VALGuard ® Vascular Access Line Guard will... Read More

MISSISSAUGA, Ontario / May 21, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2025 financial results on Wednesday, May 28, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, May 28, 2025, at 8:30am ET. To view, listen to, and... Read More

MISSISSAUGA, Ontario / May 20, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has engaged Origin Merchant Partners as its financial and strategic advisor to advise on a range of opportunities aimed at maximizing shareholder value and expanding the reach of its innovative medical technologies. With the... Read More

MISSISSAUGA, Ontario / May 15, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce the promotion of Ms. Kim Crooks to the position of Chief Operating Officer (COO), effective immediately. In addition to her new role, Ms. Crooks has been appointed to Covalon's Board of Directors. Ms. Crooks rejoined Covalon in... Read More

MISSISSAUGA, Ontario / Apr 30, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be presenting at the 2025 Bloom Burton & Co. Healthcare Investor Conference in Toronto on Tuesday, May 6, 2025 at 2:30 pm ET in Room 104 B at the Metro Toronto Convention Centre in Toronto. Brent Ashton, CEO of Covalon,... Read More

MISSISSAUGA, Ontario / Apr 17, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that they will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 4:30 pm (Local Time -PST). Brent Ashton, Covalon’s CEO will review why Covalon is in the “sweet... Read More

MISSISSAUGA, Ontario / Apr 03, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company is pleased to announce the very positive outcome for the Company with regards to the April 2, 2025 tariff announcements by U.S. President Donald Trump. Under provisions outlined in the United States-Mexico-Canada Agreement (USMCA), certain products... Read More

MISSISSAUGA, Ontario / Mar 20, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon at its Fiscal 2024 Annual Meeting of Shareholders (“AGM”) held March 19, 2025. Shareholders voted in favour of all items of business and each item of business was approved by the requisite number... Read More

MISSISSAUGA, Ontario / Mar 12, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 19, 2025 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting... Read More

MISSISSAUGA, Ontario / Feb 21, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 first quarter results for the period ended December 31, 2024 along with a number of important recent achievements and highlights. “Covalon achieved strong revenue growth, driven by the success of our US Medical... Read More

MISSISSAUGA, Ontario / Feb 19, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that it has been recognized by the TSX Venture Exchange (TSXV) as a 2025 Top 50 Company, an influential accomplishment honoring the top fifty performing companies on the TSXV over the past year. “Being included on this... Read More

MISSISSAUGA, Ontario / Feb 14, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2025 financial results on Friday, February 21, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Friday, February 21, 2025, at 8:30am ET. To view, listen to, and... Read More

MISSISSAUGA, Ontario / Feb 03, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today released a statement on the tariffs announced by President Trump on Canadian imports. While many elements to this rapidly-evolving situation are unclear and tariff implementation details are yet to be announced, the Company wishes to provide... Read More

Company ranked as #4 overall and the top Medical Device company MISSISSAUGA, Ontario / Feb 03, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has been recognized as one of the 2025 OTCQX Best 50 companies, a prestigious award that honors the top-performing OTCQX companies of 2024. This recognition is... Read More

MISSISSAUGA, Ontario / Dec 19, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2024 financial results on Tuesday, January 7, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Tuesday, January 7, 2025, at 8:30am ET. To view, listen... Read More

Visit Covalon at booth 562 to discover the latest in vascular access innovation. MISSISSAUGA, Ontario / Oct 30, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the American Nurses Credentialing Center (“ANCC”) National Magnet... Read More

Visit Covalon at booth 523 to discover the latest in compassionate vascular access solutions MISSISSAUGA, Ontario / Sep 27, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the 2024 Association for Vascular Access (“AVA”) Annual... Read More

MISSISSAUGA, Ontario / Sep 23, 2024 / Business Wire / Covalon Technologies Ltd . (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that the directors of the Company (the "Insiders") have exercised a cumulative total of 852,700 common share purchase warrants ("warrants"), generating proceeds of approximately $1.7 million CAD. In addition to the Insiders,... Read More

Visit Covalon at booth 406 to discover the latest in compassionate vascular access solutions. MISSISSAUGA, Ontario / Sep 11, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Association of... Read More

Progress on key priorities drives outstanding performance Q3 EBITDA of $1.7 million, adjusted EBITDA of $2.4 million, and EPS of $0.06 Q3 Revenue of $9.2 million, year-on-year growth of 47% Q3 Gross Profit of $5.4 million, year-on-year growth of 51% MISSISSAUGA, Ontario / Aug 21, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company,... Read More

MISSISSAUGA, Ontario / Aug 14, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2024 financial results on Wednesday, August 21, 2024, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, August 21, 2024, at 8:30am ET. To view, listen to, and... Read More

Recent changes and effective execution pave the way for strong Q2 results Q2 EBITDA of $1.7 million, Adjusted EBITDA of $2.5 million, and EPS of $0.06 Q2 year-on-year Revenue growth of 16%, focus area of US Product segment grew 54% Q2 Gross Margin increased to 63%, the highest in recent company history Achieved strong growth while reducing operating expenses by 22% versus prior year MISSISSAUGA, Ontario / May 29, 2024 /... Read More

MISSISSAUGA, Ontario / May 22, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2024 financial results on Wednesday, May 29, 2024, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, May 29, 2024, at 8:15am ET. To view, listen to, and... Read More

Visit Covalon at booth 420 to discover the latest in compassionate vascular access solutions MISSISSAUGA, Ontario / May 17, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Infusion Nurses... Read More

MISSISSAUGA, Ontario / Mar 07, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders (“AGM”) held March 6, 2024. Shareholders voted in favour of all items of business and each item of business was approved by the requisite number... Read More

MISSISSAUGA, Ontario / Feb 28, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 first quarter results for the period ended December 31, 2023. Brent Ashton, Covalon’s newly appointed Chief Executive Officer stated, “Covalon’s strong focus on our product business in the United States delivered a... Read More

MISSISSAUGA, Ontario / Feb 28, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 6, 2024 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting... Read More

MISSISSAUGA, Ontario / Jan 26, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the following management changes. Interim CFO Appointment and Transition The Company will appoint Ms. Katie Martinovich as Interim Chief Financial Officer of Covalon. Ms. Martinovich will succeed Mr. Jason Gorel, who will be stepping... Read More

Reports 2023-Q4 revenue of $6.9 million – an increase of 28%, net loss from continuing operations of $2.9 million – an improvement of $1.2 million Reports full year 2023 revenue of $26.6 million – an increase of 47%, net loss from continuing operations of $4.5 million – an improvement of $5.2 million MISSISSAUGA, Ontario / Jan 26, 2024 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV;... Read More

MISSISSAUGA, Ontario / Jan 04, 2024 / Business Wire / Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) (the " Company " or " Covalon "), an advanced medical technologies company, today announced that its Board of Directors (the “ Board ”) has appointed Mr. Brent Ashton to serve as Chief Executive Officer and a director of the Company, effective immediately. Mr. Ashton brings a wealth of experience in the MedTech industry,... Read More

BJN publication featuring VALGuard offers healthcare professionals essential Continuing Education Credits MISSISSAUGA, Ontario / Nov 15, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today proudly announced the publication of an article in the British Journal of Nursing (BJN), titled “Guarding the Central Venous Access... Read More

MISSISSAUGA, Ontario / Oct 20, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today is pleased to announce that the Company's Board of Directors has approved the grant of an aggregate of 295,000 deferred stock units (the "DSUs") to certain of its directors and officers. All DSUs were granted pursuant to the Company's omnibus... Read More

Visit Covalon at booth 715 at the AVA Conference and Exhibit to discover true compassionate vascular access solutions MISSISSAUGA, Ontario / Oct 13, 2023 / Business Wire / Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, today announced its... Read More

Discover Novel Compassionate Care Solutions at Booth 1835, McCormick Place Convention Center MISSISSAUGA, Ontario / Oct 11, 2023 / Business Wire / Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, today announced its participation in the American Nurses... Read More

MISSISSAUGA, Ontario / Sep 26, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Directors (the “Board”) has appointed Amir Boloor, Chair of the Company’s Board, as Interim Chief Executive Officer (“CEO”), effective immediately following the departure of Brian Pedlar. The Board has commenced a... Read More

Registration now open: Beyond the vein, see central vascular access through the eyes of the patient MISSISSAUGA, Ontario / Sep 25, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, proudly announces the opening of registration for... Read More

Visit Covalon at booth 425 at the Annual Association of Pediatric Hematology/Oncology Nurses Conference and Exhibit in Cleveland, Ohio to discover compassionate infection prevention technology designed for children MISSISSAUGA, Ontario / Sep 19, 2023 / Business Wire / Covalon Technologies Ltd. (the “Company” or “Covalon”)... Read More

MISSISSAUGA, Ontario / Aug 16, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its third quarter fiscal 2023 results. Brian Pedlar, Covalon’s President and CEO, said, “I am pleased to announce another strong financial quarter for Covalon. Revenue for the three months ended June 30, 2023, increased 39% to $6.3... Read More

MISSISSAUGA, Ontario / Aug 14, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2023 financial results on Wednesday, August 16, 2023, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, August 16, 2023, at 9:00am ET. To view, listen to, and... Read More

New Journal of Association for Vascular Access publication featuring VALGuard offers health care professionals Continuing Education Credits as it contributes to their professional development MISSISSAUGA, Ontario / Jul 18, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of an article in the... Read More

Visit booth 307 to learn how Covalon is creating a new standard for compassionate IV care technology designed to help protect patients from infections, pain, and trauma MISSISSAUGA, Ontario / Jun 27, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical... Read More

Visit booth 612 to discover how Covalon is setting new standards in compassionate innovation for infection prevention solutions that deliver tough protection with gentle care MISSISSAUGA, Ontario / Jun 26, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced... Read More

Registration now open: Save patient skin and stop cringeworthy dressing trauma MISSISSAUGA, Ontario / Jun 21, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced an expert-led webinar titled “Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention” will be held on Thursday, June 22,... Read More

Anesthesiologists recommend Covalon’s gentle and effective silicone solution over acrylic dressings for securing vascular insertion sites in Epidermolysis Bullosa patients prone to skin injury MISSISSAUGA, Ontario / Jun 13, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF),... Read More

MISSISSAUGA, Ontario / May 25, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its second quarter fiscal 2023 results. Brian Pedlar, Covalon’s President and CEO, said, “I am pleased to announce another strong financial quarter for Covalon. Revenue for the three months ended March 31, 2023 increased 120% to $7.2... Read More

MISSISSAUGA, Ontario / May 23, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2023 financial results on Thursday, May 25, 2023, before markets open. A conference call and webcast to discuss the financial results will be held on Thursday, May 25, 2023, at 9:00am EST. To view, listen to, and... Read More

Visit exhibit 106 to learn how Covalon is leading the charge with compassion driven innovation through gentler infection prevention solutions MISSISSAUGA, Ontario / May 16, 2023 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced it is a silver sponsor of the 2023 Neonatal/Fetal Conference: From the Womb and Beyond being... Read More

MISSISSAUGA, ON / ACCESSWIRE / April 20, 2023 / Covalon Technologies Ltd. ( the "Company" or "Covalon") (TSXV:COV) (OTCQX:CVALF), an advanced medical technologies company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 at 8:30 AM PDT. Brian Pedlar, President & CEO, will be hosting the presentation and answering questions at the conclusion of the... Read More